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ABSTRACT Many human neurodegenerative diseases are associated with amyloid ﬁbril formation. The human 99-residue b2-
microglobulin (b2m) is one of the most intensively studied amyloid-forming proteins. Recent studies show that the C-terminal
fragments 72–99, 83–89, and 91–96 form by themselves amyloid ﬁbrils in vitro and play a signiﬁcant role in ﬁbrillization of the full-
length b2m protein under acidic pH conditions. In this work, we have studied the equilibrium structures of the 17-residue fragment
83–99 in solution, and investigated its dimerizationprocessbymultiplemolecular dynamics simulations.Weﬁnd that an intertwined
dimer, with the positions of the b-strands consistent with the results for the monomer, is a possible structure for two b2m(83–89)
peptides. Based on our molecular-dynamics-generated dimeric structure, a protoﬁbril model is proposed for the full-length b2m
protein.
INTRODUCTION
More than 20 human diseases, including Alzheimer’s dis-
ease, prion diseases, and dialysis-related amyloidosis, are
associated with the pathological self-assembly of soluble
proteins into cytotoxic oligomers and amyloid ﬁbrils (1–3).
Although the proteins share very little sequence identity and
structure similarity in solution, x-ray diffraction data show
that all ﬁbrils contain a common cross b-sheet structure with
b-strands perpendicular and hydrogen bonds parallel to the
ﬁbril axis (4), suggesting a common aggregation mechanism
for all amyloidogenic proteins. Understanding the detailed
aggregation paths is an important step toward rational design
of improved therapeutics preventing neurodegenerative dis-
eases. However, due to the transient nature of oligomers, the
structures of the intermediate species are poorly understood
at an atomic level of detail.
In dialysis-related amyloidosis, the amyloidogenic com-
ponent is the 99-residue human b2-microglobulin (b2m)
protein (5), the light chain of the class I major histocompat-
ibility complex (MHC-I). After its release from the cells
expressing MHC-I, b2m is carried to the kidney where it is
degraded (6). When renal failure occurs, usually causing
high concentration of b2m, the soluble protein aggregates
into insoluble amyloid ﬁbrils (7). Deposition of b2m ﬁbrils is
a serious complication in patients who have been subjected
to long-term hemodialysis (8). The b2m ﬁbrils are often de-
posited on synovial membranes around large joints, and
therefore this type of amyloidosis characteristically induces
severe bone/joint complications. It is well established that
b2m forms amyloid ﬁbrils under acidic pH conditions (9–11),
and that the morphology of the ﬁbrils is pH-dependent (12).
Several molecular dynamics (MD) simulations on full-
length b2m and its amyloid-forming fragments have been
conducted. Two distinct b2m intermediates, suggested to be
on the paths to amyloid ﬁbril, were observed by pH-mediated
partial unfolding MD simulations at 310 K and temperature-
mediated unfolding MD simulations at 498 K (13). The role
of the single Cys25-Cys80 disulﬁde bond on b2m aggregation
was studied by discrete MD (14). The structural properties of
the fragments b2m(21–31) and b2m(83–89) were also
determined in explicit water. The b2m(21–31) monomer was
found to adopt a b-hairpin using a 4.3 ns replica exchange
molecular dynamics (REMD) simulation (15). The b2m(83–
89) dimer was studied by multiple 50-ns MD simulations at
310 K with main-chain conformational restraints, and both
parallel and antiparallel b-sheets were observed (16).
Althoughb2mhas been known as a human amyloid protein
for more than 20 years, themolecular mechanisms underlying
the self-assembly of b2m are not fully understood. Several
critical regions for amyloid ﬁbril formation have been
identiﬁed (17–19) and one of these regions spans the
C-terminal amino acids 72–99 (20). Besides the region 72–99,
it has also been found that the fragments 83–89 and 91–96 can
also form by themselves amyloid ﬁbrils in vitro (21,22). The
importance of the C-terminal region in the context of b2m
ﬁbril formation is also supported by the observation that
binding of a monoclonal antibody to residues 92–99 inhibits
amyloid formation, while binding to residues 20–41 or 63–75
has no effect onb2mﬁbrillogenesis (23). Very recently, based
on the experimental observation that the fragment 83–89 from
humanb2m forms amyloid ﬁbrils, Eisenberg et al. proposed a
ﬁbrillar model for the full-length b2m protein, in which the
amino acids 83–99 form the spine of the protoﬁbrils (21,24).
Considering the role of the C-terminal amino acids in b2m
ﬁbril formation as revealed by experiments (20,21,23) and
the role of residues 83–99 in the Eisenberg’s b2m ﬁbril (21),
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we choose the C-terminal 17-residue b2m(83–99) peptide
for study. In this work, we perform two series of molecular
dynamics (MD) simulations in explicit water at acid pH.
First, we investigate in detail the equilibrium structures of the
b2m(83–99) monomer by using three independent REMD
simulations (totaling 4.5 ms). Second, we run six indepen-
dent MD trajectories (totaling 0.815 ms) to explore the self-
assembly and the resulting aggregates of a dimer at 310 K.
We ﬁnd that, although the b2m(83–99) monomer is
essentially random coil in water, the N-terminal residues
86–89 and the C-terminal residues 95–98 have a high
intrinsic propensity to adopt aggregation-prone b-strands.
We also show that two b2m(83–99) peptides aggregate into
a b-sheet structure with two interlaced hairpins. Based on
this structure, we construct a protoﬁbril model for b2m.
MATERIALS AND METHODS
The sequence of the b2m(83–99) peptide is NHVTLSQPKIVKWDRDM. A
summary of the setup details of all simulations is given in Table 1. For each
system, we describe the method used, the label of the runs, the protonation
state of the termini, the simulation time, the temperature at which sim-
ulations were performed, and the starting conformation. As seen, we use two
protonation states of the peptide.
To mimic experimental pH ranging from 2.6 to 3.9, the side chains of
Lys, Arg, His, and Asp are protonated (Lys1, Arg1, His1, Asp0), and the
C-terminus is deprotonated (COO) (25). The N-terminus is also taken as
deprotonated (NH2), while it should be protonated, to mimic its protonation
state within the full protein. The net charge of the peptide with NH2 and
COO termini is 13. To mimic pH values smaller than 2.6, we use the
protonated NH31 and COOH termini, leading to a 15 net charge on the
peptide. Water is modeled by the explicit simple-point charge model (26).
b2m(83–99) monomer
The initial conformation is taken from the residues 83–99 of human b2-
microglobulin (PDB code: 1JNJ): an extended conformation with residues
91–94 in b-strand and the other residues in random coil. The minimum
distance between the monomer and the water box wall is 1.2 nm. The size of
the monomer system (peptide and water) is 13,833 atoms. A 1000-step
steepest descent minimization and 100-ps MD equilibration are performed
before the production run. After equilibration, the conformation is used for
the REMD run (REMD1) and the dimer MD runs. This conformation shown
in Supplementary Material Fig. S1 a is essentially extended with bends for
residues 83–87 and coils for the other residues.
Two distinct conformations generated by a MD run at 450 K and shown
in Supplementary Material Fig. S1 a are used as the starting points of the
REMD2 and REMD3 runs. The REMD1 and REMD2 runs sharing the NH2
and COO termini are used to check the convergence of the sampling. In
contrast, the REMD3 run with the NH31 and COOH termini is used to
examine the effect of the protonation state of peptide termini on the
equilibrium structures. All simulations are performed using periodic
boundary conditions in a truncated octahedron box.
b2m(83–99) dimer
For the 200-ns MD runs (Runs A–C), the peptides were put 2.25 nm apart, as
monitored by the distance of their centers of mass, and in a random
orientation (see the structure in Fig. 4 b at t ¼ 0 ns). The minimum distance
between the dimer and the water box wall is 1.0 nm. For the short trial MD
runs (5 ns each), the initial structure is described in Discussion and
Conclusions. There are 24,723 atoms in total (peptides and water).
For the two 40-ns MD runs (Runs D and E), the initial structure consists
of a preformed anti-parallel b-sheet spanning residues V93-R97 and coils
for the other residues (Supplementary Material Fig. S2, a and b. The
protonation state of peptide termini is varied. RunsD and E use a net charges
of 13 and 15 for each chain, respectively.
For the 60-ns MD run (Run F), the initial structure consists of a pre-
formed anti-parallel b-sheet (the same as the preformed anti-parallel b-sheet
in the initial structure of Run E) and a fully extended state for the other res-
idues (Supplementary Material Fig. S2 c). Here, each peptide has a net charge
of 15.
All simulations are performed using periodic boundary conditions in a
truncated octahedron box.
b2m(83–99) protoﬁbril
Two MD simulations (20 ns at 310 K and 10 ns at 330 K) are performed
using periodic boundary conditions in a rectangular water box. Here each
peptide has a 13 net charge. The protoﬁbril model was constructed by two
b-sheet layers with antiparallel arrangement. The initial distance between
the two sheets is set to 1.4 nm. The entire system has a total of 47,400 atoms.
The box dimensions are 7 nm 3 7 nm 3 10 nm.
MD and REMD simulations
The MD simulations are performed using the GROMACS software package
(27) and GROMOS96 force ﬁeld (28). The LINCS and SETTLE algorithms
are used to constrain all bond lengths of the peptides and water molecules,
TABLE 1 Setup details of all simulations
System Method Label Protonation state* Time Temperature Initial States
Monomer REMD REMD1 NH2, COO 25 300 ; 520 Fig. S1 a
Monomer REMD REMD2 NH2, COO 25 300 ; 520 Fig. S1 a
Monomer REMD REMD3 NH31, COOH 25 300 ; 520 Fig. S1 a
Dimer MD Runs A–C NH2, COO 200 3 3 310 Fig. 4 b
Dimer MD Run D NH2, COO 40 310 Fig. S2 a
Dimer MD Run E NH31, COOH 40 310 Fig. S2 b
Dimer MD Run F NH31, COOH 60 310 Fig. S2 c
C-dimer MD R1 ; 15 NH2, COO 5 3 15 310 Fig. 6
Protoﬁbril MD N/A NH2, COO 20 310 Fig. 8 a
Protoﬁbril MD N/A NH2, COO 10 330 Fig. 8 a
For each system, we describe the method used, the label of the runs, the protonation state of the termini, the simulation time (in nanoseconds), the temperature
(K), and the starting states.
*For all species, the protonation state of the side chains of Lys1, Arg1, His1, and Asp0 is kept constant.
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respectively, allowing an integration time step of 2 fs. A twin-range cutoff
1.0/1.4 nm is used for the nonbonded interactions, and a reaction-ﬁeld
correction with dielectric permittivity e ¼ 80 is employed to calculate long-
range electrostatics interactions. The temperature and the pressure are
maintained by coupling temperature and pressure baths using Berendsen’s
method (29). Although the Berendsen temperature coupling does not strictly
reproduce the canonical distribution, it is a widely used thermostat due to its
stability and efﬁciency in MD simulations. The solute and solvent are
separately coupled to external temperature and pressure baths. The temperature-
coupling constant is 0.1 ps. The pressure is kept at 1 bar using weak pressure
coupling with tp ¼ 1.0 ps (29).
The REMD simulations are carried out in the NVT ensemble. Each
REMD simulation uses 60 replicas of 25 ns in parallel. The temperature
ranges from 300 K to 520 K with exponential distribution. The swap time
between neighboring replicas is 1 ps. The acceptance ratio is between 20%
and 38%.
All trajectories are analyzed with the facilities implemented in
GROMACS software package (27). In the analysis of REMD runs, the
ﬁrst two-nanosecond trajectories were excluded. The secondary structure
content was identiﬁed using the DSSP program (30).
RESULTS
Structure and potential of mean force of
b2m(83–99) monomer
To characterize the structure of the monomer in a pH range
2.6–3.9, we perform two REMD simulations starting from
distinct conformations. REMD convergence is checked by
comparing the b-sheet probability of each residue generated
by REMD1 and REMD2 at 310 K. It can be seen from
Supplementary Material Fig. S1 that the b-sheet probability
proﬁles superpose very well, but display deviations of 6% at
positions 96 and 98, indicating a reasonable convergence of
our simulations. Analysis of the structures shows, however,
that the same main conformational space are sampled by
the REMD1 and REMD2 simulations with differences in
Boltzmann probabilities of the dominant states reaching at
most 4% at 310 K.
The REMD1 and REMD2 data are combined for analysis.
All the conformations at 310 K can be classiﬁed into ﬁve
families. The monomer is essentially random coil (71%
population, structures not shown). However, it also adopts
multiple b-hairpin-like conformations (29% population),
differing in the positions of the b-sheets and turns (including
3-, 4-, and 5-type turns as identiﬁed by DSSP program).
A representative conformation of each b-hairpin (with its
population) is shown in Fig. 1.
The secondary structure (b-sheet and turn) probability of
each residue is shown in Fig. 2 at 310, 330, and 350 K. It can
be seen from Fig. 2 a that, at 310 K, there are two dominant
regions with high b-sheet content: region A (residues 86–89,
21–25% of the time) and region B (residues 95–98, 24–34%
of the time). The region B, located in the C-terminal, has thus
a higher propensity for b-sheet than the region A located in
the N-terminal. Fig. 2 b shows that residues 91–93 spent
;21% of their time in turn conformation at 310 K. The
b-sheet content decreases gradually with increasing temper-
ature, while the turn content is stable at high temperature.
This temperature-dependent behavior of turn content has
also been observed for the amyloid fragments Ab(25–35)
and Ab(12–28) by REMD (31,32). Moreover, it has been
noted that the amount of turn content present in Ab(25–35)
is positively correlated with the ability of the peptide to ag-
gregate (33). We know that the b-sheet probabilities using
GROMOS96 might be quantitatively different using another
force ﬁeld. Using two peptides with a-helical and b-hairpin
character, Yoda et al. found that GROMOS96 has a bias
toward b conformations, while OPLS has not (34). Recent
studies on Ab(25–35) (31) and Ab(10–35) peptides (35)
show, however, very similar results using GROMOS96 and
OPLS force ﬁelds. The effects of the force ﬁeld on the
structure of b2m(83–99) peptide remains therefore to be
determined, but such a study is beyond the scope of this
work.
The potential of mean force at 310 K is plotted in Fig. 3 as
a function of the radius of gyration (rg) and the main-chain
root mean-square deviation (RMSD) from the structure A
shown in Fig. 1. Representative conformations of low free
energies are also shown. Four basins with b-hairpin
character (structures A–D in Fig. 1) are located at (rg,
RMSD) values of (0.73 nm, 0.38 nm), (0.71 nm, 0.46 nm),
(0.78 nm, 0.05 nm), and (0.68 nm, 0.31 nm), respectively. In
contrast, various random coils are distributed in the whole
free energy map.
FIGURE 1 REMD-generated hairpin-like structures
of b2m(83–99) monomer at 310 K. Their populations
are given in parentheses. The position of the C-terminal
end is indicated. Each structure is shown with the
location of the strands (top panel) and the location of
selected side-chains (bottom panel).
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To determine the effect of the NH31 and COOH termini
on the equilibrium structures at pH 2.6 or less, we performed
a 25-ns REMD3 simulation starting from Supplementary
Material Fig. S1 a. In Supplementary Material Fig. S1 b, we
see that the b-sheet probabilities of each residue from
REMD1, REMD2, and REMD3 are very similar, with
deviations of 6% at positions 96 and 98. Structural analysis
of the dominant states from the three REMD runs shows,
however, that the same main conformational space is sam-
pled, although the protonation states of peptide termini are dif-
ferent. This indicates a small effect of protonation state of the
N- and C-termini on the equilibrium structures of the b2m
(83–99) monomer.
Assembly of b2m(83–99) dimer
To explore the assembly of two b2m(83–99) peptides, three
independent MD simulations (200 ns each) are performed in
explicit water at 310 K and pH ranges from 2.6 to 3.9,
starting from a conformation described in Materials and
Methods and shown in Fig. 4 b. Two runs (Run A and Run B)
locate two interlaced b-hairpins, while Run C displays a
disordered aggregate within a 200-ns timescale (Fig. 4 a).
For the Run B, we also show the superposition of the
structure generated at 200 ns on the structure generated at 58
ns. These structures deviate by 3.6 A˚ RMSD from each
other.
The dimerization process observed in Run A is described
in Fig. 4, b and c). Starting from an initial state without any
intermolecular contacts between the C-terminal regions and
between the N-terminal regions, the C-terminal ends come in
proximity very rapidly (at t , 6 ns, Fig. 4 b). At this point,
the N-terminal residues V85-L87 adopt bend conformations,
while the other residues are random coil (Fig. 4 c). At t ¼ 11
ns, a random coil to b-strand transition occurs within the
C-terminal residues and an anti-parallel b-sheet forms be-
tween residues V93-W95 of peptide 1 (referred to as P1) and
residues W95-R97 of peptide 2 (P2) (see Fig. 4 b).
Subsequently, the N-terminal region of P2 folds over to
align with the C-terminal region of P1. At t ¼ 48 ns, the
residue P2:S88 adopts a b-bridge (Fig. 4 c). Afterwards, its
neighboring residues T86 and L87 adopt b-bridge confor-
mations successively. At t¼ 160 ns, a parallel b-sheet forms
between the C-terminal residues V93-K94 of P1 and the
N-terminal residues L87-S88 of P2. During the last 40 ns of
the simulation, the two previous strands are extended and lead
to a longer parallel b-sheet involving P1:I92-K94 and P2:T86-
S88. At t¼ 200 ns, we see that the N-terminal region of P1 has
folded back on the C-terminal region of P2 and the dimer is
assembled into two interlaced hairpins.
Although the details of the side-chain contacts and
hydrogen-bonding networks differ from the two ﬁnal
structures in Runs A and B (Fig. 4 a), both runs share the
same assembly process: the C-terminal regions of P1 and P2
come ﬁrst in proximity and form an anti-parallel b-sheet,
FIGURE 2 Secondary structure probability of each residue within the
monomer determined by DSSP (30) at 310, 330, and 350 K: (a) b-sheet
probability; (b) b-turn probability.
FIGURE 3 Potential of mean force of b2m(83–99) monomer at 310 K.
The potential of mean force is plotted as a function of the radius of gyration
(rg) and the RMSD from structure A shown in Fig. 1. Representative
structures of low free energies (in kJ/mol) are shown.
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afterwards the N-terminal region of P2 folds over to align
with the C-terminal region of P1 and self-organizes to a
parallel b-sheet, ﬁnally an interlaced-hairpin-like b-sheet
dimer forms.
To monitor the early formation of the antiparallel b-sheet
between the peptides P1 and P2 in Runs A and B, we plot the
time evolution of the total number of sidechain-sidechain
contacts (Fig. 5 a) and number of main-chain H-bonds (Fig.
5 b) between the interpeptide C-terminal amino acids
(residues I92–R97) within the ﬁrst 60 ns. Here, we consider
that two interpeptide heavy atoms are in contact if their
distances come within their van der Waals radii 1 2.8 A˚
(36), and a H-bond is formed if the donor-acceptor distance
is ,3.5 A˚ and the donor-hydrogen-acceptor angle .150.
As seen in Fig. 5 a, the number of interpeptide contacts
between the C-terminal regions increases very rapidly within
the ﬁrst 2 ns, and then ﬂuctuates at ;125 6 25 and 75 6 25
in Runs A and B, respectively. Along with these sidechain-
sidechain interactions, we also see that the H-bonds form
within 2 and 1 ns in Runs A and B, respectively.
To elucidate which interactions play a key role in the
formation process of the interpeptide antiparallel b-sheet,
Fig. 5 c shows the time evolution of the minimum distance
between three pairs of side-chains: P1:W95-P2:W95,
P1:W95-P2:K94, P1:K94-P2:D96, in the ﬁrst 60 ns of the
simulations. The expression P1:Xi-P2:Yj denotes the inter-
action between residue Xi of P1 and residue Yj of P2.
Initially, all distances are .1.5 nm. In both runs, the three
pairs of side chains come within 6.0 A˚ at 4 ns. Subsequently
in Run A, the minimum distances P1:W95-P2:K94 and
P1:K94-P2:D96 increase momentarily to 1.0 nm between
4 and 16 ns, but they decrease again after 16 ns. This indicates
that the formation and stabilization of the b-sheet results
from aromatic-aromatic interactions (W95-W95), electrostatic
interactions (K94-D96), and the interaction betweenW95 and
the hydrophobic component of K94.
FIGURE 4 Assembly of b2m(83–99) dimer. (a)
Final 200-ns structures generated by Run A (left) and
Run C (right), along with the superposition of the
structures at 58 and 200 ns (middle) in Run B. (b) Five
representative snapshots at 0, 6, 11, 160, and 200 ns of
Run A. The two peptides are in blue and red. (c) Time
evolution of secondary structure in Run A using the
DSSP program (30).
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DISCUSSION AND CONCLUSIONS
The structures of b2m(83–99) monomer have been inves-
tigated in explicit solvent by using two independent REMD
simulations at a pH range from 2.6 to 3.9 and one REMD
simulation at a pH of 2.6 or less. We ﬁnd that at 310 K the
peptide is predominantly random coil. This is consistent with
the NMR-derived dynamics of the unfolded state of full-
length b2m, where residues 85–99 were observed to be highly
dynamic and closely represented by a random coil confor-
mation (37). Our prediction of a low population of b-hairpin
for the monomer is also of interest, since the b-sheet pro-
pensity of the residues contributes to amyloid formation
(38,39). Our simulations point to two regions: region A
spanning residues 86–89 and region B spanning 95–98, and a
higher probability of the region B for b-sheet. This is fully
consistent with ab initio prediction using the CSSP method
(40).
Our 200-ns dimer simulations with the NH2 and COO
termini show that two runs, driven by interpeptide C-terminal
amino acids interactions (referred to asCC), lead to b-structure,
while an amorphous structure is reached by early NC inter-
actions (data not shown). To determine whether interpeptide
CC or NC interactions are more likely to drive the early steps
of aggregation, we repeat 15 short trial MD simulations (5 ns
each) at 310 K starting from a C-shape structure, shown in
Fig. 6, where all the Ca-Ca distances between the inter-
peptide termini are identical and set to 1.9 nm. This construc-
tion allows us therefore to examine the competition between
various scenarios, namely early formation of interpeptide
NN, CC, and NC interactions. Here, the N-terminal region
spans residues H84–Q89, and residues I92–R97 still repre-
sent the C-terminal region.
Table 2 gives the time for ﬁrst occurrence of sidechain-
sidechain contacts between the interpeptide NN, CC, and NC
regions. Here, we consider a contact formed if it persists for
at least 500 ps. In 10 of the 15 runs (Runs 1–10), we observe
early formation of CC contacts. In the remaining ﬁve runs
FIGURE 5 Analysis of the formation of the antipar-
allel b-sheet between the interpeptide C-terminal
amino acids (residues I92-R97) within the ﬁrst 60 ns
of the Runs A and B. Time evolution of (a) the total
number of sidechain-sidechain contacts; (b) the total
number of H-bonds; and (c) the minimum distance
between three pairs of side chains: P1:W95-P2:W95,
P1:W95-P2:K94, and P1:K94-P2:D96.
FIGURE 6 Two different views of the initial state of b2m(83–99) dimer
used for the 5-ns trial MD simulations. Both monomers have a C-shape
structure. The Ca-Ca distance between N1 and N2, N1 and C2, N2 and C1,
and C1 and C2 termini is identical and equal to 1.9 nm.
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(Runs 11–15), we see early formation of interpeptide NC
contacts. Interestingly, we never see early formation of NN
contacts. These results indicate that the early stages of
aggregation result from a competition between interpeptide
CC and NC interactions, and CC interactions are more likely
to play a dominant role. This is consistent with the pro-
position that the residues 92–99 play a crucial role in the
ﬁbrillization of full-length b2m (23).
Interlaced b-hairpin structures are observed in two of our
200-ns MD simulations. Both simulations start from the
same position coordinates with different initial velocities. An
important question is whether this ﬁnal intertwined structure
is dictated by the starting conformation and the protonation
state of the N- and C-termini. To this end, two independent
40-ns MD runs are performed at 310 K starting from a
preformed antiparallel b-sheet spanning residues V93–R97
with distinct protonation states of the termini: Run D with
NH2 and COO termini and Run E with NH31 and COOH
termini. As seen in Supplementary Material Fig. S2, both
simulations result in intertwined topologies with distinct
hydrogen-bonding interactions within 40-ns timescale. We
also perform a 60-ns MD simulation (Run F) with the NH31
and COOH termini starting from a short antiparallel b-sheet
spanning V93–R97, but with the rest of the amino acids fully
extended so that the competition between two side-by-side
hairpins and interlaced b-hairpins is possible. We observe
that, at t ¼ 30 ns, the C-terminal of one peptide prefers to
interact with the C-terminal of the other peptide. An
interlaced b-hairpin structure forms at t ¼ 55 ns and remains
until the end of the simulation (60 ns). These simulations
suggest that acid pH conditions do not change the propensity
for assembly into a dimeric structure with two interlaced
b-hairpins. They also clearly indicate, along with our 15 short
MD runs and previous studies of amyloid-forming peptides
(41–44), that there are multiple aggregation routes and the
dimerization pathways described in Runs A–F must be taken
as indicative only.
Our simulations show that two b2m(83–99) peptides have
a nonnegligible probability to aggregate into a b-sheet
structure. This result, in agreement with the suggestion that
the C-terminal residues of full-length b2m protein are in
b-sheet within the ﬁbrils (12,45), is of interest because the
dimer can act as a seed for larger oligomers and protoﬁbrils.
In this context, two ﬁbril models for full-length b2m were
recently proposed. Nussinov et al. (46) constructed a cross-b
helical model based on protein docking, using NMR
spectroscopy (47) and limited proteolysis data at pH $ 4
(48) suggesting that the N- and C-terminal b-strands (amino
acids 12–18 and 91–95) do not participate in the amyloid
ﬁbril. In contrast, Eisenberg et al. recently proposed a
protoﬁbril model, where the protein core (residues 1–80)
retains its native (in solution) conformation and the zipper-
spine model is characterized by two hairpins, where the
segment 83–89 binds to the same segment in other molecules
forming the b-sheet spine of the amyloid (21). In this model,
shown in Fig. 7, a and b, residues 90–91 form the b-turn, and
residues 92–98 and 83–89 form the strands of b-hairpin.
Interestingly, the participation of amino acids 83–99 in the
b-sheet structure is supported by recent H/D exchange and
limited proteolysis of full-length b2m ﬁbrils formed at pH
2.5 at low ionic strength, demonstrating the plasticity of the
morphologies and digestion patterns of ﬁbrils as a function
on the experimental conditions used (12,45).
Based on our simulations, we can propose an alternative
model, where the hairpins are not side-by-side assembled,
but rather are interlaced. Since the interlaced hairpins
generated by Runs A, B, and F differ at an atomic level of
detail, it is not clear which ending structure would be the
TABLE 2 Time (in nanoseconds) for ﬁrst occurrence of sidechain-sidechain contacts between the interpeptide NN, CC,
and NC regions
Runs R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R14 R15
NN 4.1 3.2 nd nd nd 1.0 4.7 nd nd nd 3.5 1.5 3.7 nd 3.0
CC 3.0 0.8 2.0 1.7 2.0 0.5 1.5 1.0 2.2 1.7 2.2 nd 4.1 4.5 nd
NC 3.6 3.2 nd 3.1 nd nd 1.6 nd nd 1.9 3.5 1.0 0.3 nd 4.2
CN 4.8 nd 2.5 nd 2.5 0.7 nd nd nd 2.0 0.9 4.5 3.5 3.5 2.8
The N-terminal and C-terminal regions span H84-Q89 and I92-R97, respectively. The term nd stands for no deﬁned interactions within 5 ns.
FIGURE 7 Two protoﬁbril models for the full-length b2m. (a and b)
Eisenberg’s model with side-by-side-hairpin b-sheet dimers, and the amino
acids labeled. (c and d) Our model with interlaced-hairpin-like b-sheet
dimers.
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most likely intertwined dimer. We therefore construct a
model, shown in Fig. 7, c and d, based on three assumptions:
1), the protein core retains its in solution conformation; 2),
residues 88–92 form the turn and residues 83–87 and 93–97
form the strands; and 3), the interpeptide W95-W95, K94-
D96, and W95-K94 interactions (detected by our MD
simulations) provide the main forces within the dimer. Our
model is then modeled by maximizing the interpeptide hydro-
phobic interactions and hydrogen-bonding interactions (49).
Interestingly, the constructed model displays a hydrophobic-
network repeat V85-W95-W95-V85 along the axis of the
protoﬁbril.
It follows that our model shares many common structural
features with the model proposed by Eisenberg et al., except
that the position of the turns differs and there is a b-strand
swapping. Such a swapping, a consequence of minimal
frustration (50), is usually seen for domains in large proteins
(51–53). To determine whether our model is stable, a
protoﬁbril consisting of two layers of four units (each unit
modeled by two interlaced hairpins) is subject to two MD
runs at 310 K (20 ns) and 330 K (10 ns). We recognize that
this timescale is too short to validate our model, but
microsecond simulations are still out of reach (49). Fig. 8 a
shows the initial structure for MD. The Ca RMSD from the
structure at 1 ns is given in Fig. 8 b. The time evolution of the
number of main chain H-bonds is shown in Fig. 8 c. Because
of ﬁnite-size effects in the protoﬁbril, we focus on the
properties of the two central units of both layers. We see that
the Ca RMSD increases slightly in the ﬁrst ﬁve nanoseconds
and then stabilizes at ;3.0 A˚, and the main chain H-bonds
are rather stable at both temperatures. The increase in RMSD
results from both the ﬂexibility of each interlaced hairpin
(contribution of 1.5 A˚ RMSD) and the twisting motion of
each unit with respect to the other.
In summary, this work indicates that an intertwined dimer
is a possible structure for two b2m(83–99) peptides.
Whether this state is truly the most favorable or only a
product of the starting conformations used remains to be
determined using all-atom and coarse-grained REMD sim-
ulations (54,55). Experimental measurements, clearly
needed to clarify the b-sheet packing and isotope-edited IR
spectroscopy, which can differentiate between antiparallel
and parallel b-sheets (56), would be helpful. However, based
on insights from our dimer simulations, we propose an
antiparallel arrangement of the C-terminal residues within
the full-length b2m protein ﬁbrils and the key roles of the
amino acids K94, W95, and D96 in the aggregation process,
leading to one of the possible organizations of b2m ﬁbrils.
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